Share

November 18, 2014; 83 (21) Views & Reviews

Dietary treatment in adults with refractory epilepsy

A review

Pavel Klein, Ivana Tyrlikova, Gregory C. Mathews
First published October 29, 2014, DOI: https://doi.org/10.1212/WNL.0000000000001004
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
612

Share

Article Information

vol. 83 no. 21 1978-1985
DOI: 
https://doi.org/10.1212/WNL.0000000000001004
PubMed: 
25355830
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received March 12, 2014
  • Accepted in final form August 20, 2014
  • First Published October 29, 2014.

Article Versions

Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. Pavel Klein, MBBChir,
    2. Ivana Tyrlikova, MD and
    3. Gregory C. Mathews, MD, PhD
  1. Pavel Klein, MBBChir,
    2. Scientific Advisory Boards:

    1. Accorda,Inc: advisory board Eisai: advisory board UC Davis: DSMB, UC Davis Allopregnanolone TBI Clinical Trial (no compensation received to-date)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Speaker's bureau: UCB Pharma, Inc; Glaxo Smith Kline, travel expenses related to speaking Cyberonics: travel to a company-sponsored meeting

    Editorial Boards:

    1. NONE

    Patents:

    1. U.S. Patent Application No. 62/024,827 �KETOGENIC FOOD COMPOSITIONS AND USES THEREOF� Applicant: OH! MBF Reference No.: 207953-9003-US00 Application No. 62/024,827 The application was filed on July 15, 2014 (after the submission of the final revision of the present manuscript).The patent application is for use of ketogenic foods for various madical conditions.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Self-employed

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Speaker's bureau: UCB Pharma, Inc; Glaxo Smith Kline; Eisai; Sunovion

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Ivana Tyrlikova, MD and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. 1) Mid-Atlantic Epilepsy and Sleep Center,Clinical Research Associate, 1.5 year

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Gregory C. Mathews, MD, PhD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD.
  1. Correspondence to Dr. Klein: kleinp{at}epilepsydc.com

Article usage

Article usage: October 2014 to October 2023

AbstractFullPdfSource
Oct 2014812015Highwire
Nov 20142679101146Highwire
Dec 201465310944Highwire
Jan 20154244840Highwire
Feb 20153203419Highwire
Mar 20152963622Highwire
Apr 20152082313Highwire
May 20153341611Highwire
Jun 2015243175Highwire
Jul 20152041915Highwire
Aug 2015186103Highwire
Sep 20151861212Highwire
Oct 20151992516Highwire
Nov 20151561513Highwire
Dec 201518676Highwire
Jan 201617496Highwire
Feb 2016100115Highwire
Mar 20166763Highwire
Apr 20168772Highwire
May 20168154Highwire
Jun 2016651113Highwire
Jul 20167621Highwire
Aug 20166633Highwire
Sep 20166288Highwire
Oct 20168934Highwire
Nov 20169133Highwire
Dec 20163932Highwire
Jan 201710982Highwire
Feb 20175155Highwire
Mar 20177766Highwire
Apr 20177012Highwire
May 20178155Highwire
Jun 20174832Highwire
Jul 20174800Highwire
Aug 20175834Highwire
Sep 20179467Highwire
Oct 20176524Highwire
Nov 20177823Highwire
Dec 201710400Highwire
Jan 201811735Highwire
Feb 201813341Highwire
Mar 201823121Highwire
Apr 2018192114Highwire
May 201824900Highwire
Jun 201816031Highwire
Jul 201828343Highwire
Aug 201813953Highwire
Sep 201810513Highwire
Oct 201817345Highwire
Nov 201816643Highwire
Dec 201815322Highwire
Jan 201913740Highwire
Feb 201912785Highwire
Mar 201910112Highwire
Apr 201912544Highwire
May 201913063Highwire
Jun 201911262Highwire
Jul 201911562Highwire
Aug 20197720Highwire
Sep 201911345Highwire
Oct 201910731Highwire
Nov 201913971Highwire
Dec 201911813Highwire
Jan 202014777Highwire
Feb 202013944Highwire
Mar 202014000Highwire
Apr 20207911Highwire
May 20208110Highwire
Jun 202010151Highwire
Jul 20207801Highwire
Aug 20207844Highwire
Sep 202012400Highwire
Oct 202013901Highwire
Nov 202011886Highwire
Dec 202012641Highwire
Jan 202111042Highwire
Feb 20219000Highwire
Mar 202111931Highwire
Apr 202111933Highwire
May 202110842Highwire
Jun 20218600Highwire
Jul 20218920Highwire
Aug 202118421Highwire
Sep 202111121Highwire
Oct 202111224Highwire
Nov 202112621Highwire
Dec 202111645Highwire
Jan 202210311Highwire
Feb 202214523Highwire
Mar 202214600Highwire
Apr 202217627Highwire
May 202216433Highwire
Jun 202213910Highwire
Jul 202215102Highwire
Aug 20228712Highwire
Sep 202210311Highwire
Oct 202211110Highwire
Nov 202213810Highwire
Dec 202211520Highwire
Jan 202312822Highwire
Feb 202311900Highwire
Mar 202311611Highwire
Apr 20238234Highwire
May 20239022Highwire
Jun 20238132Highwire
Jul 20238352Highwire
Aug 202313511Highwire
Sep 202312840Highwire
Oct 202317610Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Topics Discussed

Alert Me

Recommended articles